RLMD
Relmada Therapeutics, Inc. - Common Stock (RLMD)
$84
About Relmada Therapeutics, Inc. - Common Stock (RLMD)
Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Details
Daily high
$4.28
Daily low
$3.84
Price at open
$4.28
52 Week High
$8.00
52 Week Low
$2.42
Market cap
444.8M
Dividend yield
-
Volume
864,497
Avg. volume
1.8M
P/E ratio
-4.48
Relmada Therapeutics, Inc. - Common Stock News
Details
Daily high
$4.28
Daily low
$3.84
Price at open
$4.28
52 Week High
$8.00
52 Week Low
$2.42
Market cap
444.8M
Dividend yield
-
Volume
864,497
Avg. volume
1.8M
P/E ratio
-4.48